The Biopharmaceutical Contract Manufacturing Market is on the cusp of a profound transformation, driven by relentless innovation, groundbreaking technological advancements, and an ever-evolving therapeutic landscape. As the demand for sophisticated biologics and novel treatment modalities surges, Contract Development and Manufacturing Organizations (CDMOs) are poised to play an even more...